Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Raveen Stephen Stallon Illangeswaran, Saswati Das, Daniel Zechariah Paul, Vikram Mathews & Poonkuzhali Balasubramanian. (2019)
A personalized approach to acute myeloid leukemia therapy: current options. Pharmacogenomics and Personalized Medicine 12, pages 167-179.
Read now
Read now
Sung-Min Ju, Jun Lee, Jun-Gue Kang, Sun-Oh Jeong, Jang-Ho Park, Hyun-Ock Pae, Guem-San Lee, Won-Sin Kim, Yeoung-Su Lyu & Byung-Hun Jeon. (2015) Nardostachys chinensis induces granulocytic differentiation with the suppression of cell growth through p27Kip1 protein-related G0/G1 phase arrest in human promyelocytic leukemic cells. Pharmaceutical Biology 53:7, pages 1002-1009.
Read now
Read now
Pier Paolo Piccaluga, Giovanni Martinelli & Michele Baccarani. (2006) Advances in the treatment for haematological malignancies. Expert Opinion on Pharmacotherapy 7:6, pages 721-732.
Read now
Read now
S. Amadori, P. Fenaux, H. Ludwig, M. O’Dwyer & M. Sanz. (2005) Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent. Current Medical Research and Opinion 21:3, pages 403-411.
Read now
Read now
Articles from other publishers (2)
Michael J. Spinella, Sarah J. Freemantle & Ethan Dmitrovsky. 2015. The Retinoids. The Retinoids
557
574
.
Srdan Verstovsek, Francis Giles, Alfonso Quintás‐Cardama, Nichole Perez, Farhad Ravandi‐Kashani, Miloslav Beran, Emil Freireich & Hagop Kantarjian. (2006) Arsenic derivatives in hematologic malignancies: a role beyond acute promyelocytic leukemia?. Hematological Oncology 24:4, pages 181-188.
Crossref
Crossref